immunotherapy

Breakthroughs in immunotherapy: A chat with renowned American immunologist and oncologist, Dr. Carl June

Agilent has steadily been developing innovative cell-based solutions that enable researchers and developers to overcome the challenges and capture the opportunities faced in the rapidly growing field of immunotherapy. Recently David Ferrick, an executive in the Cell Analysis Division at Agilent, caught up with Carl June, a professor at the University of Pennsylvania and Abramson Cancer Center, to discuss their perspectives on these unique challenges and opportunities.

Dr. June has not served as a consultant for Agilent and has not received payments from Agilent.

For Research Use Only. Not for use in diagnostic procedures.

©2018 Agilent Technologies